Immuron Ltd
IMRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660046
No open-market purchases or sales by Immuron Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $82.2K in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Immuron Ltd changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 7 | 8 | +1 |
| Shares | 171.8K | 91.0K | −80.8K (−47.0%) |
| Value | $429.5K | $305.0K | −$124.5K (−29.0%) |
New holders (3)
Institutions that held Immuron Ltd at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Old Mission Capital LLC | 12,317 | $41.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 3,037 | $10.0K | 0.00% |
| BNP Paribas Arbitrage, SA | 300 | $1.01K | 0.00% |
Sold out (2)
Institutions that held Immuron Ltd at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Renaissance Technologies LLC | 34,313 | $86.0K |
| Susquehanna International Group, LLP | 14,615 | $37.0K |